Catalyst Wire Dossier Catalyst Wire Dossier

Progerinin

· PRG Science & Technology Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Progerinin, covering 2026-01-23 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Study to Determine Optimal Dose and Evaluate Safety, Tolerability, and Pharmacokinetics of Progerinin in Patients With Hutchinson-Gilford Progeria Syndrome (HGPS) [Phase 2]

See pricing